Transcription factors shape gene expression by binding to genomic cis-regulatory elements and then recruiting nucleosome remodeling factors, the RNA polymerase holoenyzme, and other transcriptional coactivators. What determines where a transcription factor binds in vivo? For most eukaryotic transcription factors (TFs), the answer to this question is not known. We have recently analyzed two yeast bHLH proteins, Cbf1 and Tye7, which have nearly identical DNA binding preferences in vitro, but bind at almost completely non-overlapping target loci in vivo. We found that Cbf1 utilizes homotypic cooperativity to achieve its specificity, while Tye7 binds in a TF collective, a phenomenon that has been described only recently in Drosophila, but is poorly understood. We hypothesize that homotypic cooperativity and collective binding are widely used by eukaryotic TFs to achieve their specificities in vivo. We will test this hypothesis by quantifying the contribution of these two mechanisms to the in vivo binding of all yeast transcription factors. We will also dissect a small number of these complexes in detail. We will investigate the binding specificity of the human bHLH transcription factor Usf1, which is a candidate drug target because of its involvement in obesity and metabolic disease. The completion of this work will deepen our understanding of the factors that govern the in vivo specificities of transcription factors. Furthermore, by gaining an understanding of the protein-protein contacts that regulate Usf1 binding, we will uncover interactions that can be disrupted for therapeutic benefit.

Public Health Relevance

Cells differentiate, divide, and respond to their environments by modulating gene transcription. The proteins that effect these changes are transcription factors, and they do so by binding specific regulatory DNA sequences in the genome. We currently do not understand how transcription factors bind at the correct locations in the cell. What is clear, however, is that much of a transcription factor?s specificity is achieved through cooperative interactions with other transcription factors. This proposal seeks to understand the rules of this combinatorial binding, focusing on the simplest eukaryotic system, the yeast S. cerevisiae, and then applying this knowledge to understand the binding of the human transcription factor Usf1. Usf1 plays a central role in obesity and metabolic disease. By discovering the protein-protein contacts that govern Usf1 binding, we hope to find new interactions that will be targets for small molecule drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM123203-03
Application #
9937822
Study Section
Genomics, Computational Biology and Technology Study Section (GCAT)
Program Officer
Adkins, Ronald
Project Start
2018-06-21
Project End
2022-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Washington University
Department
Genetics
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Avey, Denis; Sankararaman, Sumithra; Yim, Aldrin K Y et al. (2018) Single-Cell RNA-Seq Uncovers a Robust Transcriptional Response to Morphine by Glia. Cell Rep 24:3619-3629.e4